Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Tribulus and Reduced Systolic Blood Pressure

Doses used in studies

g/day: 6 (median 6, IQR 6–6) — 1 study

Time to effect

Median: 8.6 weeks · IQR 8.6 weeks–8.6 weeks · Range 8.6 weeks–8.6 weeks — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
Safety parameters were found to be within normal limits.
from: Efficacy of Khār-i-khasak (Tribulus terrestris Linn.) in prehypertension: a randomized, do

1 of 1 paper

Efficacy of Khār-i-khasak (Tribulus terrestris Linn.) in prehypertension: a randomized, double-blind, placebo-controlled trial.
- 2021-04-01
- RCT
- Journal of complementary & integrative medicine 18(4)
- - Mansoor Ahmad Siddiqui
  - Malik Itrat
  - Abdul Mobeen
  - Md Imran Khan
- PubMed: 33793146
- DOI: 10.1515/jcim-2020-0322
3 Insights on
- Reduced Systolic Blood Pressure
- High evidence
- Clinical
Both systolic and diastolic blood pressure showed a significant decline in the test group (p<0.001) as compared to the placebo group. The average decline in systolic/diastolic blood pressure was -7.7/5.5 mmHg in the test group
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Dose
6 g/day in three divided doses